PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1951574-9	1991	The triazole antifungals, terconazole and itraconazole, combine a high affinity for Candida P-45014DM with an exceptionally low effect on mammalian cytochrome P-450.	terconazole	26-37	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	148-164	
2677363-7	1989	Terconazole has far greater selectively for yeast cytochrome P-450 than for mammalian microsomal cytochrome P-450.	terconazole	0-11	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	97-113	
2677363-4	1989	The basic mechanism of action of terconazole, inhibition of fungal cytochrome P-450, is similar to that of the imidazoles.	terconazole	33-44	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	67-83	
2677363-5	1989	However, because of the additional nitrogen atom in the triazole ring and the lipophilic tail, terconazole establishes a firmer and longer-lasting link with the membrane-bound fungal cytochrome P-450.	terconazole	95-106	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	183-199	
2677363-7	1989	Terconazole has far greater selectively for yeast cytochrome P-450 than for mammalian microsomal cytochrome P-450.	terconazole	0-11	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	50-66	
2677363-10	1989	The high affinity and selectivity of terconazole for fungal cytochrome P-450 and its potent in vitro and in vivo activity indicate that the drug may well become a significant agent for the treatment of fungal disease.	terconazole	37-48	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	60-76